September 16, 2019
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Darmerica LLC Issues Voluntary Nationwide Recall of Quinacrine Dihydrochloride Due to A Labeling Error
- National Drug Code Directory (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
- CDER Pilot Grant Program: Standard Core Clinical Outcome Assessments (COAs) and their Related Endpoints
- Expanded Access Part 2: How to Submit a Single Patient IND (September 2019)
- Expanded Access Part 3: How to Complete Form FDA 3926 for Initial Submissions (September 2019)
- Expanded Access Part 4: How to Complete Form FDA 3926 for Follow-up Submissions (September 2019)
- Transcript: Expanded Access Part 2: How to Submit a Single Patient IND (September 2019)
- Transcript: Expanded Access Part 3: How to Complete Form FDA 3926 for Initial Submissions
- Transcript: Expanded Access Part 4: How to Complete Form FDA 3926 for Follow-up Submissions (September 2019)
.png)
No hay comentarios:
Publicar un comentario